| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenues | $2.50B+39.3% | $1.80B+31.5% | $1.37B |
| Cost of goods sold | $1.41B+39.0% | $1.01B+32.6% | $765.2M |
| Operations, general and administrative | $523.1M+54.5% | $338.5M+22.5% | $276.3M |
| Sales and marketing | $495.7M+46.8% | $337.7M+31.1% | $257.5M |
| Research and development | $46.3M+157.4% | $18.0M+22.8% | $14.6M |
| Total operating expenses | $2.48B+44.9% | $1.71B+30.1% | $1.31B |
| Operating income | $25.4M-70.9% | $87.2M+65.2% | $52.8M |
| Stock amendment expense (Note 11) | -$32.7M | $0 | $0 |
| Interest income | $7.7M+24.2% | $6.2M+113.9% | $2.9M |
| Interest expense | -$231K-135.7% | -$98K-197.0% | -$33K |
| Other income (expense), net | -$946K+53.0% | -$2.0M-384.7% | $707K |
| Income (loss) before income taxes | -$794K-100.9% | $91.2M+61.9% | $56.3M |
| Provision (benefit) for income taxes | -$17.0M-172.9% | $23.4M+55.1% | $15.1M |
| Net income | $16.2M-76.1% | $67.9M+64.4% | $41.3M |
| Adjustments to net income attributable to common stockholders (Note 2) | $172.9M+581.5% | $25.4M+18.3% | $21.4M |
| Net income (loss) attributable to common stockholders | -$156.6M-468.6% | $42.5M+114.3% | $19.8M |
| Basic (in dollars per share) | -$1360.00-389.4% | $470.00+113.6% | $220.00 |
| Diluted (in dollars per share) | -$1360.00-389.4% | $470.00+113.6% | $220.00 |
| Basic (in shares) | 115.0M+26.7% | 90.8M+0.0% | 90.8M |
| Diluted (in shares) | 115.0M+26.7% | 90.8M+0.0% | 90.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.